buthionine sulfoximine has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappai, R; Ciccotosto, GD; Cranston, GA; Crouch, PJ; Du, T; Kocak, G; Masters, CL; White, AR | 1 |
| Bains, JS; Shaw, CA | 1 |
| Easton, N; Fry, JR; Green, AR; Marsden, CA; O'Shea, E | 1 |
3 other study(ies) available for buthionine sulfoximine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation.
Topics: 3T3 Cells; Animals; Buthionine Sulfoximine; Cell Death; Cerebral Cortex; Copper; DNA Damage; Enzyme Inhibitors; Free Radicals; Gene Expression Regulation; Glutathione; Glutathione Synthase; Mice; Neurodegenerative Diseases; Neurons; Tumor Suppressor Protein p53 | 2008 |
Did consumption of flour bleached by the agene process contribute to the incidence of neurological disease?
Topics: Buthionine Sulfoximine; Chlorides; Flour; Food Contamination; Food Handling; Glutamine; Glutathione; Humans; Methionine Sulfoximine; Models, Neurological; Nervous System; Neurodegenerative Diseases; Nitrogen Compounds; Oxidative Stress | 1998 |
Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia.
Topics: Animals; Brain; Brain Chemistry; Buthionine Sulfoximine; Drug Therapy, Combination; Fever; Glutathione; Hydroxyindoleacetic Acid; Liver; Male; Maleates; N-Methyl-3,4-methylenedioxyamphetamine; Neurodegenerative Diseases; Paroxetine; Rats; Rats, Inbred Strains; Serotonin; Treatment Outcome | 2002 |